Cooper Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
CGH
CNB
AP
P
QCM
Cooper Financial Group's GILD Position: Q2 2026 in Review
Cooper Financial Group reduced its Gilead Sciences (GILD) stake by 23% in Q2 2026, selling an estimated $176K and leaving 4,403 shares worth $556K. The position accounts for 0.05% of the portfolio, ranked #250.
Cooper Financial Group first reported a position in GILD in Q4 2018 and has held it in 18 quarters since. The position peaked at $800K in Q1 2026. 328 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Cooper Financial Group held 4,403 shares of Gilead Sciences worth $556K as of Q2 2026.
- Cooper Financial Group sold 1,339 Gilead Sciences shares in Q2 2026, an estimated $176K.
- Gilead Sciences made up 0.05% of Cooper Financial Group's portfolio in Q2 2026, its #250 holding.
- Cooper Financial Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 18 quarters since.
- Cooper Financial Group's Gilead Sciences position peaked at $800K in Q1 2026.
- 328 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.